The uniform lack of actionable gene alterations of conventional lung adenocarcinomas; namely, EGFR mutation, EML4-ALK rearrangement, and ROS1 rearrangement are common knowledge with regards to the SMARCA4-dNSCLC tumors [28]. This evidence concerns the gene SMARCA4 and lung adenocarcinoma.